As one of the famous business writers Peter Drucker implied “Profit for a company is like oxygen for a person; if you don't have enough of it, you are out of the game. (Senge, 2008, p:326) In our world, most of the companies operate as if their purpose is breathing. Certainly, the purpose of a company is to maximize profit but also they can make both profit and contribution. (Senge, 2008) This is the point where we can start talking about CSR because it is the idea of businesses to be aware of how they can contribute to their social and economical environment.
In this paper, I will try to imply the definition and the importance of R&D in pharmaceutical business, concluding that R&D is CSR, but also by illustrating how closely R&D is linked to the profit that the company can obtain from its investments.
|School:||The American University of Paris (France)|
|Department:||Cross-Cultural and Sustainable Business Management|
|Source:||MAI 56/02M(E), Masters Abstracts International|
|Subjects:||Management, Pharmaceutical sciences|
|Keywords:||Corporate social responsibility, Pharmaceutical companies, Profit, Research and development|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be